[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE280161T1 - Imidazolverbindungen als alpha2-adrenorezeptoren antagonisten - Google Patents

Imidazolverbindungen als alpha2-adrenorezeptoren antagonisten

Info

Publication number
ATE280161T1
ATE280161T1 AT01942360T AT01942360T ATE280161T1 AT E280161 T1 ATE280161 T1 AT E280161T1 AT 01942360 T AT01942360 T AT 01942360T AT 01942360 T AT01942360 T AT 01942360T AT E280161 T1 ATE280161 T1 AT E280161T1
Authority
AT
Austria
Prior art keywords
alpha2
imidazole compounds
adrenoreceptor antagonists
adrenoreceptor
antagonists
Prior art date
Application number
AT01942360T
Other languages
English (en)
Inventor
Paavo Huhtala
Arto Karjalainen
Antti Haapalinna
Jyrki Lehtimaeki
Arja Karjalainen
Raimo Virtanen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Application granted granted Critical
Publication of ATE280161T1 publication Critical patent/ATE280161T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01942360T 2000-01-14 2001-01-12 Imidazolverbindungen als alpha2-adrenorezeptoren antagonisten ATE280161T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20000073A FI20000073A0 (fi) 2000-01-14 2000-01-14 Uusia imidatsolijohdannaisia
PCT/FI2001/000030 WO2001051472A1 (en) 2000-01-14 2001-01-12 New imidazole derivatives

Publications (1)

Publication Number Publication Date
ATE280161T1 true ATE280161T1 (de) 2004-11-15

Family

ID=8557065

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01942360T ATE280161T1 (de) 2000-01-14 2001-01-12 Imidazolverbindungen als alpha2-adrenorezeptoren antagonisten

Country Status (30)

Country Link
EP (1) EP1261588B1 (de)
JP (1) JP2003519688A (de)
KR (1) KR20020084091A (de)
CN (1) CN1187336C (de)
AR (1) AR029432A1 (de)
AT (1) ATE280161T1 (de)
AU (1) AU769896B2 (de)
BR (1) BR0107644A (de)
CA (1) CA2397283A1 (de)
CZ (1) CZ20022358A3 (de)
DE (1) DE60106572T2 (de)
DK (1) DK1261588T3 (de)
EE (1) EE200200389A (de)
ES (1) ES2228884T3 (de)
FI (1) FI20000073A0 (de)
GC (1) GC0000218A (de)
HK (1) HK1049999B (de)
HU (1) HUP0301008A3 (de)
IL (1) IL150506A0 (de)
MX (1) MXPA02006872A (de)
NO (1) NO323117B1 (de)
NZ (1) NZ519919A (de)
PE (1) PE20011230A1 (de)
PL (1) PL207281B1 (de)
PT (1) PT1261588E (de)
RU (1) RU2265598C2 (de)
SI (1) SI1261588T1 (de)
SK (1) SK286320B6 (de)
WO (1) WO2001051472A1 (de)
ZA (1) ZA200205301B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20002756A0 (fi) * 2000-12-15 2000-12-15 Orion Yhtymae Oyj Uusi hoitomenetelmä
TW200930291A (en) 2002-04-29 2009-07-16 Bayer Cropscience Ag Pesticidal heterocycles
FI20022159A0 (fi) * 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä
DE102004035322A1 (de) * 2004-07-21 2006-02-16 Universität des Saarlandes Selektive Hemmstoffe humaner Corticoidsynthasen
WO2008046757A1 (en) 2006-10-19 2008-04-24 F. Hoffmann-La Roche Ag Aminomethyl-4-imidazoles
CN101535298A (zh) 2006-11-16 2009-09-16 弗·哈夫曼-拉罗切有限公司 取代的4-咪唑类化合物
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
AR090557A1 (es) * 2012-04-02 2014-11-19 Orion Corp DERIVADOS IMIDAZOLICOS AGONISTAS ADRENERGICOS a2

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
GB2244431A (en) * 1990-05-31 1991-12-04 Farmos Oy Treatment of age related memory impairment and other cognitive disorders
US5541211A (en) * 1991-06-18 1996-07-30 Orion-Yhtyma Oy Administration of atipamezole to elicit a yohimbine-like alpha-adrenoreceptor antagonistic noradrenergic transmission
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
AU744798B2 (en) * 1997-12-04 2002-03-07 Allergan, Inc. Substituted imidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors
US6503935B1 (en) * 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
TWI283669B (en) * 1999-06-10 2007-07-11 Allergan Inc Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors

Also Published As

Publication number Publication date
BR0107644A (pt) 2002-10-08
GC0000218A (en) 2006-03-29
PL356884A1 (en) 2004-07-12
AU2853201A (en) 2001-07-24
HK1049999A1 (en) 2003-06-06
CN1187336C (zh) 2005-02-02
AR029432A1 (es) 2003-06-25
NO20023298D0 (no) 2002-07-08
DE60106572D1 (de) 2004-11-25
FI20000073A0 (fi) 2000-01-14
CN1395567A (zh) 2003-02-05
KR20020084091A (ko) 2002-11-04
RU2002121777A (ru) 2004-01-10
EE200200389A (et) 2003-10-15
ZA200205301B (en) 2003-10-02
PL207281B1 (pl) 2010-11-30
RU2265598C2 (ru) 2005-12-10
SI1261588T1 (en) 2005-02-28
JP2003519688A (ja) 2003-06-24
MXPA02006872A (es) 2003-01-28
SK9982002A3 (en) 2003-03-04
HUP0301008A3 (en) 2004-01-28
CZ20022358A3 (cs) 2007-12-19
DE60106572T2 (de) 2006-02-09
CA2397283A1 (en) 2001-07-19
PT1261588E (pt) 2005-02-28
EP1261588B1 (de) 2004-10-20
PE20011230A1 (es) 2001-12-08
NO20023298L (no) 2002-09-06
WO2001051472A1 (en) 2001-07-19
WO2001051472A9 (en) 2003-01-23
ES2228884T3 (es) 2005-04-16
AU769896B2 (en) 2004-02-05
HUP0301008A2 (hu) 2003-10-28
HK1049999B (zh) 2005-05-13
SK286320B6 (en) 2008-07-07
DK1261588T3 (da) 2005-02-14
NZ519919A (en) 2003-10-31
EP1261588A1 (de) 2002-12-04
IL150506A0 (en) 2003-02-12
NO323117B1 (no) 2007-01-08

Similar Documents

Publication Publication Date Title
NO20030472D0 (no) Imidazolderivater
NO20023424L (no) Kortikotropin-frigjörende faktorantagonister
DE60134094D1 (de) C7-taxanester als antitumormittel
DE60012031D1 (de) Piperazin verbindungen als tachykinin-antagonisten
DE60112064D1 (de) Benzoamid-piperidin verbindungen als substanz p-antagonisten
DE60108108D1 (de) Heteroaromatische alkynylphenyl-verbindungen als glukokinase-aktivatoren
ATE384053T1 (de) Triazolderivate als tachykininrezeptor- antagonisten
NO20026196L (no) Kinazolinditosylatsalt-forbindelser
ATE339417T1 (de) Biphenyl - sulfonamide als duale angiotensin - endothelin - rezeptor - antagonisten
ATE277933T1 (de) Thiophenverbindungen zur verwendung als antikrebsmittel
DK1619192T3 (da) Arylkondeserede azapolycykliske forbindelser
DK1358165T3 (da) Imidazolderivater
ATE291575T1 (de) N-carbamoyloxyalkyl-substituierte azolium- verbindungen
ATE439344T1 (de) Muscarin-antagonisten
DE60140368D1 (de) Substitutuierte imidazole als tafia inhibitoren
DE60118569D1 (de) 4-phenylpyridin-derivate als neurokinin-1-rezeptor-antagonisten
DE60114852D1 (de) Chinazolin-derivate als alpha-1 adrenerge antagonisten
ATE245653T1 (de) Imidazolverbindungen als phosphodiesterase vii- hemmer
ATE428420T1 (de) Substituierte 8-arylchinoline als phosphodiesterase-4-hemmer
ATE286018T1 (de) Biphenylderivate als neurokinin-1 antagonisten
DE50206096D1 (de) Substituierte benzoäbüazepin-2-on-verbindungen als schmerzmittel
NO20025659L (no) Heterocykliske forbindelser
ATE280161T1 (de) Imidazolverbindungen als alpha2-adrenorezeptoren antagonisten
ATE372338T1 (de) Deshalogenverbindungen
ATE264301T1 (de) Muscarin-antagonisten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1261588

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee